M1908 Tenofovir Disoproxil Fumarate (TDF) for the Treatment of HBeAg-Negative Chronic Hepatitis B: Week 72 TDF Data and Week 24 Adefovir Dipivoxil Switch Data (Study 102)

Adefovir Dipivoxil ◽

57 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 102)

10.1016/s0168-8278(08)60059-8 ◽

2008 ◽

Vol 48 ◽

pp. S26 ◽

Cited By ~ 23

Author(s):

P. Marcellin ◽

I. Jacobson ◽

F. Habersetzer ◽

H. Senturk ◽

P. Andreone ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-negative chronic Hepatitis B: Week 72 TDF data and week 24 Adefovir dipivoxil switch data (Study 102)

Zeitschrift für Gastroenterologie ◽

10.1055/s-0028-1089453 ◽

2008 ◽

Vol 46 (09) ◽

Author(s):

P Buggisch ◽

M Manns ◽

S Mauss ◽

T Berg ◽

G Teuber ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp3261 ◽

2018 ◽

Vol 23 (8) ◽

pp. 711

Author(s):

George V Papatheodoridis ◽

Eirini I Rigopoulou ◽

Margarita Papatheodoridi ◽

Kalliopi Zachou ◽

Vassilios Xourafas ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Term Therapy ◽

Hbsag Loss ◽

Long Term Therapy ◽

903 TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL

10.1016/s0168-8278(09)60905-3 ◽

2009 ◽

Vol 50 ◽

pp. S328 ◽

Cited By ~ 6

Author(s):

T. Berg ◽

B. Moller ◽

H. Trinh ◽

S. Chan ◽

P. Marcellin ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Viral Replication ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp3256 ◽

2018 ◽

Vol 23 (8) ◽

pp. 677-685 ◽

Cited By ~ 19

Author(s):

George V Papatheodoridis ◽

Eirini I Rigopoulou ◽

Margarita Papatheodoridi ◽

Kalliopi Zachou ◽

Vassilios Xourafas ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Term Therapy ◽

Hbsag Loss ◽

Long Term Therapy ◽

494 Two-state modeling of virological and biochemical efficacy plus liver biopsies demonstrate efficacy of adefovir dipivoxil in HBeAg-negative chronic hepatitis B over four or five years

10.1016/s0168-8278(06)80494-0 ◽

2006 ◽

Vol 44 ◽

pp. S184

Author(s):

S. Hadziyannis ◽

N. Tassopoulos ◽

T.T. Chang ◽

E.J. Heathcote ◽

G. Kitis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Liver Biopsies ◽

Long-Term Therapy with Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B

New England Journal of Medicine ◽

10.1056/nejmoa042957 ◽

2005 ◽

Vol 352 (26) ◽

pp. 2673-2681 ◽

Cited By ~ 379

Author(s):

Stephanos J. Hadziyannis ◽

Nicolaos C. Tassopoulos ◽

E. Jenny Heathcote ◽

Ting-Tsung Chang ◽

George Kitis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Term Therapy ◽

Long Term Therapy ◽

Tenofovir disoproxil fumarate is superior to adefovir dipivoxil in lamivudine-resistant chronic hepatitis B virus (HBV) infection,

Inpharma Weekly ◽

10.2165/00128413-200514750-00037 ◽

2005 ◽

Vol &NA; (1475) ◽

pp. 16

Author(s):

&NA;

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Hbv Infection ◽

Chronic Hepatitis B Virus ◽

B Virus

18 OUTCOME OF HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHB) 5 YEARS AFTER DISCONTINUATION OF LONG TERM ADEFOVIR DIPIVOXIL (ADV) TREATMENT

10.1016/s0168-8278(09)60020-9 ◽

2009 ◽

Vol 50 ◽

pp. S9-S10 ◽

Cited By ~ 13

Author(s):

S. Hadziyannis ◽

V. Sevastianos ◽

I. Rapti

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Adefovir Dipivoxil ◽

Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Negative, Chronic Hepatitis B Patients: A Global Phase 3 Study

Gastroenterology ◽

10.1016/s0016-5085(17)33661-2 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1086

Author(s):

Maurizia Rossana Brunetto ◽

Young-Suk Lim ◽

Edward Gane ◽

Wai-Kay Seto ◽

Marina Osipenko ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Efficacy And Safety ◽

Phase 3 ◽

Tenofovir Alafenamide ◽